Latest Blogs

May 05, 2021
Many years ago I treated a patient with a rare sarcoma. We recently reconnected and she generously shared her experience of being treated for and now considered "cured" of her rare tumor, with a reminder that the cancer experience is unique to every individual.
May 04, 2021
If luck, as Louis Pasteur noted, favors the prepared mind, how will oncologists not only prepare but extend cognitive capacity in an era where both medical knowledge and the scope of human endeavor that physicians must address continue to increase exponentially?
Apr 27, 2021
With the current pace of progress in cancer care, urgent implementation of cost-effectiveness training curriculum in fellowship training programs will be indispensable, shares Dr. Samer Al Hadidi. 
Apr 12, 2021
"A successful mentorship is mutually beneficial for the mentor and mentee, where each party has to recognize and understand what the other is offering and whether it fits each career path," said Dr. Atlal Abusanad.
Subscribe to this column

Gilberto Lopes, MD, MBA

Gilberto de Lima Lopes Jr., MD, MBA, FAMS, a medical oncologist, is medical director for international programs and associate director for global oncology at the Sylvester Comprehensive Cancer Center and associate professor of clinical medicine at the University of Miami in Florida. He returned to the United States after 10 years in Asia and Latin America and has dedicated much of his time to the issues of cancer control and access to medications in low- and middle-income countries. Dr. Lopes is the editor in chief of ASCO's Journal of Global Oncology, associate editor for the ASCO eLearning Editorial Board, 2016-2017 chair of the International Clinical Trials Workshop Working Group, and global health track leader for the Cancer Education Committee, among other volunteer roles. Follow him on Twitter @GlopesMd.

Disclosure.

Apr 05, 2016
This is the story of how a populist Congress approved the medication that wasn't, and oncologists in the country are waiting to see if an enfeebled president will be able to veto the bill.
Feb 24, 2016
This is the story of how an eager chemistry professor and a well-intended but misguided federal judge transformed cancer care and drug development in Brazil into a convoluted soap opera.
Feb 03, 2016
The decision to scale up the provision of oral chemotherapy was a watershed event in the regulation of private health insurance in Brazil; however, prospects for expanded access to such medicines in the public health system are bleak in the short term.
Jan 21, 2016
Price discrimination is an inequitable-sounding, but important, concept of charging different prices for the same product or service in different markets or segments of a market, usually based on consumers’ ability to pay.
Dec 09, 2015
In 2012, in an attempt to answer the call to prioritize interventions, my colleagues and I, with support from the Asian Oncology Summit and Lancet Oncology, discussed and agreed upon a resource-stratified consensus on the management of colon cancer.
Oct 06, 2015
Low- and middle-income countries must invest in cancer control in a cost-effective, stepwise fashion to achieve the best results in the shortest amount of time with the most rational allocation of resources.

Pages